In science

TwinStrand Biosciences Announces Filing of Patent Infringement Lawsuit Against Guardant Health

Retrieved on: 
Tuesday, August 3, 2021

TwinStrand Biosciences, Inc. announced today that it filed a patent infringement lawsuit against Guardant Health, Inc. (Nasdaq: GH).

Key Points: 
  • TwinStrand Biosciences, Inc. announced today that it filed a patent infringement lawsuit against Guardant Health, Inc. (Nasdaq: GH).
  • TwinStrand and its exclusive licensor, the University of Washington, filed the lawsuit in the United States District Court in Delaware.
  • The complaint alleges that Guardant Health infringes multiple patents covering TwinStrands proprietary Duplex Sequencing methods for generating highly accurate DNA sequence data.
  • TwinStrand Biosciences is leading the way in identifying ultra-low frequency genomic variants that are undetectable by conventional methods.

Global Polyethylene Naphthalate Market Analysis & Forecasts, 2012-2019 & 2020-2027 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 21, 2021

The "Polyethylene Naphthalate - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Polyethylene Naphthalate - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Amid the COVID-19 crisis, the global market for Polyethylene Naphthalate estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at a CAGR of 7.6% over the analysis period 2020-2027.
  • Packaging, one of the segments analyzed in the report, is projected to record a 8.3% CAGR and reach US$743.1 Million by the end of the analysis period.
  • The U.S. Market is Estimated at $323 Million, While China is Forecast to Grow at 11.5% CAGR
    The Polyethylene Naphthalate market in the U.S. is estimated at US$323 Million in the year 2020.

Global Flexible Foam Market Trajectory & Analytics, 2021-2027 - U.S. Market is Estimated at $11.3 Billion, While China is Forecast to Grow at 7.4% CAGR - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 21, 2021

The "Flexible Foam - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Flexible Foam - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Polyurethane, one of the segments analyzed in the report, is projected to record a 4.8% CAGR and reach US$31.6 Billion by the end of the analysis period.
  • The U.S. Market is Estimated at $11.3 Billion, While China is Forecast to Grow at 7.4% CAGR
    The Flexible Foam market in the U.S. is estimated at US$11.3 Billion in the year 2020.
  • In the global Polypropylene segment, USA, Canada, Japan, China and Europe will drive the 4.8% CAGR estimated for this segment.

DGAP-News: Paul Ehrlich Institute Allows Heidelberg Pharma to Start a Phase I/IIa Clinical Trial with ATAC Candidate HDP-101

Retrieved on: 
Monday, July 19, 2021

Ladenburg, Germany, 19 July 2021 - Heidelberg Pharma AG (FSE: HPHA) today announced that the German authority Paul Ehrlich Institute, Langen, Germany, (PEI) has approved the study design of the planned Phase I/IIa clinical trial with the ATAC candidate HDP-101.

Key Points: 
  • Ladenburg, Germany, 19 July 2021 - Heidelberg Pharma AG (FSE: HPHA) today announced that the German authority Paul Ehrlich Institute, Langen, Germany, (PEI) has approved the study design of the planned Phase I/IIa clinical trial with the ATAC candidate HDP-101.
  • After approval by the ethics committee and signing the contracts, we will soon start with the initiation of the German study centers.
  • The first part of the trial is a Phase I dose escalation study to determine the maximum tolerated dose of HDP-101.
  • The proprietary lead candidate HDP-101 is a BCMA ATAC for multiple myeloma and will enter clinical development shortly.

TGen looks beyond COVID-19 as it advances pathogen sequencing

Retrieved on: 
Thursday, July 15, 2021

Using genomic sequencing to track the COVID-19 pandemic in Arizona, TGen launched the Arizona COVID-19 Sequencing Dashboard , which now includes more than 26,000 sequenced genomes of Arizona COVID-19 positive samples, one of the nation's most robust such efforts.

Key Points: 
  • Using genomic sequencing to track the COVID-19 pandemic in Arizona, TGen launched the Arizona COVID-19 Sequencing Dashboard , which now includes more than 26,000 sequenced genomes of Arizona COVID-19 positive samples, one of the nation's most robust such efforts.
  • One of the technologies that has advanced TGen's sequencing of the COVID-19 virus is plexWell, a platform from Massachusetts-based seqWell Inc ., which has allowed TGen to accelerate its sequencing by nearly 10-fold.
  • These advances significantly increased TGen's sequencing output, according to the TGen study: "This allowed for a high throughput, cost-effective means of processing large numbers of samples with minimal laboratory personnel and infrastructure."
  • We continue to work on enhancements and new protocols to meet the demands of TGen and other COVID sequencing centers.

Global Polyurethane Foam Market (2020 to 2026) - by Type and Region - ResearchAndMarkets.com

Retrieved on: 
Wednesday, July 14, 2021

The "Polyurethane Foam Market Research Report by Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Polyurethane Foam Market Research Report by Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.
  • What is the market size and forecast of the Global Polyurethane Foam Market?
  • What is the market share of the leading vendors in the Global Polyurethane Foam Market?
  • What modes and strategic moves are considered suitable for entering the Global Polyurethane Foam Market?

TruDiagnostic licenses Mitotic Clock developed by Van Andel Institute and Cedars-Sinai Medical Center

Retrieved on: 
Tuesday, July 13, 2021

GRAND RAPIDS, Mich. & LEXINGTON, Ky., July 13, 2021 /PRNewswire/ -- Today, TruDiagnostic licensed a Mitotic Clock developed by epigenetic pioneers at Van Andel Institute and Cedars-Sinai Medical Center, and will be working with Van Andel Institute to continue to develop and refine this new clock.

Key Points: 
  • GRAND RAPIDS, Mich. & LEXINGTON, Ky., July 13, 2021 /PRNewswire/ -- Today, TruDiagnostic licensed a Mitotic Clock developed by epigenetic pioneers at Van Andel Institute and Cedars-Sinai Medical Center, and will be working with Van Andel Institute to continue to develop and refine this new clock.
  • A fully developed Mitotic Clock could become extremely useful in both clinical research and personalized medicine...
    Mitosis is the process by which nearly all human and animal cells divide and replicate.
  • A Mitotic Clock looks at how many times a cell has undergone replication.
  • A fully developed Mitotic Clock could become extremely useful in both clinical research and personalized medicine with its ability to detect:
    Cell Senescence.

Worldwide Next-Generation Sequencing Industry to 2026 - Key Players Include Agilent Technologies, 10x Genomics and BGI Group Among Others

Retrieved on: 
Monday, July 12, 2021

Next-generation sequencing, or high-throughput sequencing, refers to the process of determining the sequence of nucleotides in a section of the DNA.

Key Points: 
  • Next-generation sequencing, or high-throughput sequencing, refers to the process of determining the sequence of nucleotides in a section of the DNA.
  • It includes procedures such as sequencing by synthesis (SBS), ion semiconductor sequencing, nanopore sequencing and single-molecule real-time (SMRT) sequencing.
  • Key Questions Answered in This Report:
    How has the global next-generation sequencing market performed so far and how will it perform in the coming years?
  • What is the structure of the global next-generation sequencing market and who are the key players?

Global Next-Generation Sequencing Market (2021 to 2026) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Monday, July 12, 2021

The "Next-Generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Next-Generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering.
  • The global next generation sequencing (NGS) market exhibited double-digit growth during 2015-2020.
  • Looking forward, the publisher expects the global next generation sequencing (NGS) market to grow at a CAGR of 19.5% during 2021-2026.
  • It includes procedures such as sequencing by synthesis (SBS), ion semiconductor sequencing, nanopore sequencing and single-molecule real-time (SMRT) sequencing.

Eclipse Co-Founder and CEO Tom O'Brien Passes Away

Retrieved on: 
Thursday, July 8, 2021

THE COLONY, Texas, July 8, 2021 /PRNewswire/ -- Tom O'Brien, 68, CEO and founder of Eclipse, unexpectedly passed away on July 3, 2021.

Key Points: 
  • THE COLONY, Texas, July 8, 2021 /PRNewswire/ -- Tom O'Brien, 68, CEO and founder of Eclipse, unexpectedly passed away on July 3, 2021.
  • Eclipse leadership issued the following statement: "We are deeply saddened by the sudden passing of Tom O'Brien.
  • Tom was wise to make provision for a straight path forward for Eclipse in the case of a tragedy such as this.
  • His younger brother and Eclipse Co-founder, Paul O'Brien will be stepping into the position as CEO.